Yes.......IMO 1c is the bottom (<$10m market cap) and it will rise. At that price it represents a very attractive proposition on a risk : reward basis.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025